As people crossing 40 years old, the joints start to get trouble, Chondroitin is recomended in most of the books & M.D. recomendation...
I will write about my recomendation's about herbs in my future article.
Demand for natural joint care creates emerging food category
25/11/2004 - Ingredients supplier Cargill says new food applications containing the joint health supplement chondroitin will allow companies to captialise on the growing interest in preventative joint care.
Joint health has come under the media spotlight in recent weeks following the withdrawal Merck’s blockbuster arthritis and pain-reliever drug, Vioxx, at the end of September. A study found that patients were twice as likely to suffer a heart attack or stroke as when taking this drug - worth $2.5 billion in sales in the US alone during 2003 – than when on placebo.
The news raised questions about similar products available to arthritis sufferers and is expected to prompt a surge of interest in natural joint care products.
“We have seen a significant pick-up in people looking to develop products with chondroitin,” product manager at Cargill health food and technologies Lee Knudsen confirmed.
“There is increasing awareness that some of these drugs might not be available in the future and that we need to be preventative,” he explained to NutraIngredients.com.
Chondroitin already rakes in up to $1 billion in retail sales in the US, with Europe estimated to generate around $400-600 million. And with price pressure on raw materials – bovine and other animal cartilage – the ingredient is becoming more expensive. It currently ranges from around $65 per kg to $150 for the higher quality material. Demand for natural joint care creates emerging food category
I will write about my recomendation's about herbs in my future article.
Demand for natural joint care creates emerging food category
25/11/2004 - Ingredients supplier Cargill says new food applications containing the joint health supplement chondroitin will allow companies to captialise on the growing interest in preventative joint care.
Joint health has come under the media spotlight in recent weeks following the withdrawal Merck’s blockbuster arthritis and pain-reliever drug, Vioxx, at the end of September. A study found that patients were twice as likely to suffer a heart attack or stroke as when taking this drug - worth $2.5 billion in sales in the US alone during 2003 – than when on placebo.
The news raised questions about similar products available to arthritis sufferers and is expected to prompt a surge of interest in natural joint care products.
“We have seen a significant pick-up in people looking to develop products with chondroitin,” product manager at Cargill health food and technologies Lee Knudsen confirmed.
“There is increasing awareness that some of these drugs might not be available in the future and that we need to be preventative,” he explained to NutraIngredients.com.
Chondroitin already rakes in up to $1 billion in retail sales in the US, with Europe estimated to generate around $400-600 million. And with price pressure on raw materials – bovine and other animal cartilage – the ingredient is becoming more expensive. It currently ranges from around $65 per kg to $150 for the higher quality material. Demand for natural joint care creates emerging food category
Comments